Laura Ruth Alder
Assistant Professor of MedicineOverview
Areas of Research/Interest
- Optimizing biomarker directed treatment for late-stage lung cancer
- Optimizing treatment for patients with lung cancer and brain metastases
- Finding novel targets in early and advanced stage lung cancer
- Optimizing access to health care in women and minorities facing lung cancer
Positions
Assistant Professor of Medicine in the School of Medicine
2023 School of Medicine
Member of the Duke Cancer Institute in the School of Medicine
2024 School of Medicine
Education
M.D. 2017
2017 University of Queensland (Australia)
Resident, INTERNAL MEDICINE
2020 Virginia Commonwealth University
Clinical Trials
Publications, Grants & Awards
- Grants (3)
- Academics Articles (11)
- Conference Pages (1)
An Open-Label, Phase 1/2 Study of ORIC-114 as a Single Agent or in Combination with Chemotherapy, in Patients with Advanced Solid Tumors Harboring an EGFR or HER2 Alteration
ORIC Pharmaceuticals, Inc.
A randomized pilot study comparing the feasibility of using a virtual agent vs. an off-site human agent to onboard oncology patients to remote patient AI monitoring devices
NTT DATA Americas, Inc.
BGBC016 STK11 NSCLC
BerGenBio ASA
DCI Centers, Cancer Types & Labs
Offices & Contact
20 Duke Medicine Circle
Durham, NC
27710 Box 90827
Durham, NC
27708-0827
Durham, NC
27710 Box 90827
Durham, NC
27708-0827